X4 Pharmaceuticals (XFOR) Change in Inventory (2024 - 2025)

X4 Pharmaceuticals' (XFOR) quarterly Change in Inventory came in at $399000.0 in Q4 2025, up 7.26% YoY from $372000.0 in Q4 2024, and down 56.15% on a QoQ basis from $910000.0 in Q3 2025.

X4 Pharmaceuticals (XFOR) Change in Inventory (2024 - 2025) Analysis & Trends

X4 Pharmaceuticals (XFOR) has 2 years of Change in Inventory data on file, last reported at $399000.0 in Q4 2025.

  • Quarterly Change in Inventory rose 7.26% year-over-year to $399000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (down 41.0% YoY) and the FY2025 annual result came in at $1.7 million, down 41.0% from the prior year.
  • Change in Inventory retreated to $399000.0 in Q4 2025, from $910000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $1.6 million in Q3 2024 to a low of $81000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 27.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 28.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 47.15 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -2,188.52
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -280,000.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 12.97 Mn
10 X4 Pharmaceuticals 533.17 Mn 338.08 Mn 7.19 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 399,000.00
Dec 31, 2025 399,000.00
Sep 30, 2025 910,000.00
Sep 30, 2025 910,000.00
Jun 30, 2025 81,000.00
Jun 30, 2025 81,000.00
Mar 31, 2025 272,000.00
Mar 31, 2025 272,000.00
Dec 31, 2024 372,000.00
Dec 31, 2024 372,000.00
Sep 30, 2024 1.61 Mn
Sep 30, 2024 1.61 Mn
Jun 30, 2024 831,000.00
Jun 30, 2024 831,000.00